Qube Research & Technologies LTD 23and Me Holding Co. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in 23and Me Holding Co. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 79,362 shares of ME stock, worth $26,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,362Holding current value
$26,189% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ME
# of Institutions
159Shares Held
100MCall Options Held
270KPut Options Held
349K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$6.42 Million18.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$5.09 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY10.2MShares$3.38 Million0.5% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$1.75 Million1.76% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.94MShares$1.63 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $85.7M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...